{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:47:37Z","timestamp":1782179257609,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intravenous drug abuse (IVDA) has increased the incidence of infective endocarditis. Standard management includes traditional open surgery and more recently described percutaneous tricuspid valve debulking. Study goals were to compare clinical outcomes and identify financial differences between percutaneous tricuspid debulking and tricuspid surgery for isolated tricuspid valve endocarditis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single-center, retrospective cohort patient study of isolated tricuspid valve endocarditis was performed. Patients underwent either percutaneous debulking with the AngioVac system (n=14, 83% IVDA) or tricuspid valve surgery (n=23, 76% IVDA). Length of stay, readmission rates, mortality, echocardiographic parameters, hematologic markers, transfusion rates, and total charges for index hospitalization were evaluated between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In patients who underwent either percutaneous debulking or open surgery, length of stay (17\u00b117 vs 20\u00b113 days, p=0.48), 30-day readmission (29% vs 26%, p=0.87), in-hospital mortality (7% vs 0%, p=0.20), and 30-day mortality (7% vs 0%, p=0.20) were not statistically different. One-year mortality (21% vs 4%, p=0.11) trended toward but did not reach significance. Postoperative tricuspid valve regurgitation (2.5\u00b11.1 vs 1.0\u00b10.3, p&lt;0.0001) and transfusion rates (2\u00b13 vs 6\u00b16 units, p=0.02) were significantly different between therapies. Total charges for hospitalization were not statistically different ($557,066\u00b1457,520 vs $571,615\u00b1324,254, p=0.91).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Tricuspid debulking is a potential alternative to surgery for patients with infective tricuspid endocarditis. Similar outcomes, costs, and avoidance of prosthetic material in patients with active IVDA are potential benefits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13019-026-04061-5","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T18:13:47Z","timestamp":1777918427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes and financial comparison of percutaneous debulking versus surgical management of tricuspid endocarditis"],"prefix":"10.1186","volume":"21","author":[{"given":"Sanjhai L.","family":"Ramdeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahaj S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement J.","family":"Rajakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan G.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent A.","family":"Strohecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Buczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian D.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Friscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Bresticker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikhar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo R.","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"4061_CR1","unstructured":"Opioid Facts and Statistics, Feb. 7, 2023. https:\/\/www.hhs.gov\/opioids\/statistics\/index.html"},{"key":"4061_CR2","doi-asserted-by":"publisher","first-page":"108350","DOI":"10.1016\/j.drugalcdep.2020.108350","volume":"218","author":"C Florence","year":"2021","unstructured":"Florence C, Luo F, Rice K. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Depend. 2021;218:108350.","journal-title":"Drug Alcohol Depend"},{"key":"4061_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/SAR.S108302","volume":"7","author":"JA Boscarino","year":"2016","unstructured":"Boscarino JA, Kirchner HL, Pitcavage JM, et al. Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system. Subst Abuse Rehabilitation. 2016;7:131\u201341. https:\/\/doi.org\/10.2147\/SAR.S108302.","journal-title":"Subst Abuse Rehabilitation"},{"issue":"4","key":"4061_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/clc.23162","volume":"42","author":"MC Bates","year":"2019","unstructured":"Bates MC, Annie F, Jha A, Kerns F. Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact. Clin Cardiol. 2019;42(4):432\u20137.","journal-title":"Clin Cardiol"},{"issue":"11","key":"4061_CR5","doi-asserted-by":"publisher","first-page":"101353","DOI":"10.1016\/j.cpcardiol.2022.101353","volume":"47","author":"M Mhanna","year":"2022","unstructured":"Mhanna M, Beran A, Al-Abdouh A, et al. AngioVac for Vegetation Debulking in Right-sided Infective Endocarditis: A Systematic Review and Meta-Analysis. Curr Probl Cardiol Nov. 2022;47(11):101353. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101353.","journal-title":"Curr Probl Cardiol Nov"},{"key":"4061_CR6","doi-asserted-by":"crossref","unstructured":"Wurcel AG, Anderson JE, Chui KK, et al. Increasing infectious endocarditis admissions among young people who inject drugs. Oxford University Press; 2016. p. ofw157.","DOI":"10.1093\/ofid\/ofw157"},{"issue":"1","key":"4061_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7326\/M18-2124","volume":"170","author":"AJ Schranz","year":"2019","unstructured":"Schranz AJ, Fleischauer A, Chu VH, Wu L-T, Rosen DL. Trends in drug use\u2013associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data. Ann Intern Med. 2019;170(1):31\u201340.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4061_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/jocs.14009","volume":"34","author":"I Hameed","year":"2019","unstructured":"Hameed I, Lau C, Khan FM, et al. AngioVac for extraction of venous thromboses and endocardial vegetations: a meta-analysis. J Card Surg. 2019;34(4):170\u201380.","journal-title":"J Card Surg"},{"issue":"10","key":"4061_CR9","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/jocs.13806","volume":"33","author":"C Basman","year":"2018","unstructured":"Basman C, Rashid U, Parmar YJ, Kliger C, Kronzon I. The role of percutaneous vacuum-assisted thrombectomy for intracardiac and intravascular pathology. J Card Surg. 2018;33(10):666\u201372.","journal-title":"J Card Surg"},{"issue":"3","key":"4061_CR10","first-page":"E475","volume":"98","author":"S Bangalore","year":"2021","unstructured":"Bangalore S, Alviar CL, Vlahakis S, Keller N. Tricuspid valve vegetation debulking using the AngioVac system. Catheter Cardiovasc Interv. 2021;98(3):E475\u20137.","journal-title":"Catheter Cardiovasc Interv"},{"key":"4061_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10840-019-00555-6","volume":"55","author":"A Rusia","year":"2019","unstructured":"Rusia A, Shi AJ, Doshi RN. Vacuum-assisted vegetation removal with percutaneous lead extraction: a systematic review of the literature. J Interventional Cardiac Electrophysiol. 2019;55:129\u201335.","journal-title":"J Interventional Cardiac Electrophysiol"},{"issue":"1","key":"4061_CR12","first-page":"120","volume":"27","author":"P Wallenhorst","year":"2018","unstructured":"Wallenhorst P, Rutland J, Gurley J, Guglin M. Use of AngioVac for Removal of Tricuspid Valve Vegetation. J Heart Valve Dis. 2018;27(1):120\u20133.","journal-title":"J Heart Valve Dis"},{"issue":"6","key":"4061_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.21037\/acs.2019.11.04","volume":"8","author":"CT Starck","year":"2019","unstructured":"Starck CT, Dreizler T, Falk V. The AngioVac system as a bail-out option in infective valve endocarditis. Annals Cardiothorac Surg. 2019;8(6):675.","journal-title":"Annals Cardiothorac Surg"},{"issue":"15","key":"4061_CR14","doi-asserted-by":"publisher","first-page":"e017293","DOI":"10.1161\/JAHA.120.017293","volume":"9","author":"H Shmueli","year":"2020","unstructured":"Shmueli H, Thomas F, Flint N, Setia G, Janjic A, Siegel RJ. Right-sided infective endocarditis 2020: challenges and updates in diagnosis and treatment. J Am Heart Association. 2020;9(15):e017293.","journal-title":"J Am Heart Association"},{"issue":"6","key":"4061_CR15","first-page":"1008","volume":"81","author":"AA Divekar","year":"2013","unstructured":"Divekar AA, Scholz T, Fernandez JD. Novel percutaneous transcatheter intervention for refractory active endocarditis as a bridge to surgery\u2013AngioVac aspiration system. Catheter Cardiovasc Interv. 2013;81(6):1008\u201312.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"4061_CR16","first-page":"1009","volume":"90","author":"B George","year":"2017","unstructured":"George B, Voelkel A, Kotter J, Leventhal A, Gurley J. A novel approach to percutaneous removal of large tricuspid valve vegetations using suction filtration and veno-venous bypass: a single center experience. Catheter Cardiovasc Interv. 2017;90(6):1009\u201315.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"4061_CR17","first-page":"508","volume":"99","author":"TA Hammad","year":"2022","unstructured":"Hammad TA, Abu-Omar Y, Shishehbor MH. Novel intracardiac echocardiography\u2010guided catheter\u2010based removal of inoperable tricuspid valve vegetation. Catheter Cardiovasc Interv. 2022;99(2):508\u201311.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"4061_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/imi.0000000000000189","volume":"10","author":"S Hosoba","year":"2015","unstructured":"Hosoba S, Mori M, Furtado AD, Lattouf OM. Extraction of right-sided vegetation with use of an aspiration catheter system. Innovations. 2015;10(5):357\u20139.","journal-title":"Innovations"},{"issue":"8","key":"4061_CR19","doi-asserted-by":"publisher","first-page":"e10010","DOI":"10.7759\/cureus.10010","volume":"12","author":"SM Winkle","year":"2020","unstructured":"Winkle SM, Gaballa S, Memon A, Miller JB, Curfiss R Serratia marcescens tricuspid valve vegetation and successful use of the AngioVac\u00ae system. Cureus. 2020;12(8):e10010. https:\/\/doi.org\/10.7759\/cureus.10010.","journal-title":"Cureus"},{"key":"4061_CR20","doi-asserted-by":"crossref","unstructured":"Overview. September 17, 2023.","DOI":"10.4324\/9781032674346-1"},{"issue":"7","key":"4061_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.carrev.2018.02.005","volume":"19","author":"AA Jabaar","year":"2018","unstructured":"Jabaar AA, Jenkins JS. The role of vacuum assisted thrombectomy (AngioVac) in treating chronic venous thromboembolic disease. Systematic review and a single center\u2019s experience. Cardiovasc Revascularization Med. 2018;19(7):799\u2013804.","journal-title":"Cardiovasc Revascularization Med"},{"issue":"4","key":"4061_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11886-022-01658-9","volume":"24","author":"T Enezate","year":"2022","unstructured":"Enezate T, Alkhatib D, Raja J, Chinta V, Patel M, Omran J. AngioVac for Minimally Invasive Removal of Intravascular and Intracardiac Masses: a Systematic Review. Curr Cardiol Rep Apr. 2022;24(4):377\u201382. https:\/\/doi.org\/10.1007\/s11886-022-01658-9.","journal-title":"Curr Cardiol Rep Apr"},{"issue":"1","key":"4061_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/europace\/euz283","volume":"01","author":"CT Starck","year":"2020","unstructured":"Starck CT, Schaerf RHM, Breitenstein A, et al. Transcatheter aspiration of large pacemaker and implantable cardioverter-defibrillator lead vegetations facilitating safe transvenous lead extraction. Europace Jan. 2020;01(1):133\u20138. https:\/\/doi.org\/10.1093\/europace\/euz283.","journal-title":"Europace Jan"},{"issue":"9S1","key":"4061_CR24","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/S0735-1097(19)32579-3","volume":"73","author":"BJ George","year":"2019","unstructured":"George BJ, Santos P, Donaldson K, et al. A retrospective comparison of tricuspid valve surgery to tricuspid valve vegetation debulking with AngioVac for isolated tricuspid valve endocarditis. J Am Coll Cardiol. 2019;73(9S1):1973\u20131973.","journal-title":"J Am Coll Cardiol"},{"key":"4061_CR25","doi-asserted-by":"crossref","unstructured":"Alkhouli M, Alqahtani F, Alhajji M, Berzingi CO, Sohail MR. Clinical and economic burden of hospitalizations for infective endocarditis in the United States. Elsevier; 2020. pp. 858\u201366.","DOI":"10.1016\/j.mayocp.2019.08.023"},{"issue":"14","key":"4061_CR26","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.jacc.2018.02.011","volume":"71","author":"SV Deo","year":"2018","unstructured":"Deo SV, Raza S, Kalra A, et al. Admissions for infective endocarditis in intravenous drug users. J Am Coll Cardiol. 2018;71(14):1596\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4061_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3408-y","volume":"18","author":"ME Gray","year":"2018","unstructured":"Gray ME, Rogawski McQuade ET, Scheld WM, Dillingham RA. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study. BMC Infect Dis. 2018;18(1):1\u20139.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4061_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/icvts\/ivv397","volume":"22","author":"OB \u00d8sterdal","year":"2016","unstructured":"\u00d8sterdal OB, Salminen P-R, Jordal S, Sjursen H, Wendelbo \u00d8, Haaverstad R. Cardiac surgery for infective endocarditis in patients with intravenous drug use. Interact Cardiovasc Thorac Surg. 2016;22(5):633\u201340.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"4061_CR29","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jtcvs.2016.02.072","volume":"152","author":"JB Kim","year":"2016","unstructured":"Kim JB, Ejiofor JI, Yammine M, et al. Surgical outcomes of infective endocarditis among intravenous drug users. J Thorac Cardiovasc Surg. 2016;152(3):832\u201341. e1.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"4061_CR30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.athoracsur.2015.03.019","volume":"100","author":"NK Shrestha","year":"2015","unstructured":"Shrestha NK, Jue J, Hussain ST, et al. Injection drug use and outcomes after surgical intervention for infective endocarditis. Ann Thorac Surg. 2015;100(3):875\u201382.","journal-title":"Ann Thorac Surg"},{"issue":"44","key":"4061_CR31","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075\u2013128.","journal-title":"Eur Heart J"},{"issue":"9","key":"4061_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jaccas.2022.02.019","volume":"04","author":"YN Akhtar","year":"2022","unstructured":"Akhtar YN, Barry Iv N, Foster MT, et al. Case Series of Percutaneous Mechanical Aspiration of Mitral Valve Endocarditis. JACC Case Rep May. 2022;04(9):523\u20138. https:\/\/doi.org\/10.1016\/j.jaccas.2022.02.019.","journal-title":"JACC Case Rep May"},{"issue":"4","key":"4061_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ccd.30319","volume":"100","author":"S Memon","year":"2022","unstructured":"Memon S, Goldman S, Hawthorne KM, Gnall EM. Percutaneous transeptal mitral valve endocarditis debulking with AngioVac aspiration system. Catheter Cardiovasc Interv Oct. 2022;100(4):667\u201373. https:\/\/doi.org\/10.1002\/ccd.30319.","journal-title":"Catheter Cardiovasc Interv Oct"},{"issue":"18","key":"4061_CR34","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.jcin.2023.07.021","volume":"25","author":"CM Lane","year":"2023","unstructured":"Lane CM, El Sabbagh A, Alkhouli MA. Transseptal Debulking of Mitral Valve Endocarditis Using On-Circuit Aspiration Thrombectomy System and Multimodal Embolic Protection. JACC Cardiovasc Interv Sep. 2023;25(18):2324\u20136. https:\/\/doi.org\/10.1016\/j.jcin.2023.07.021.","journal-title":"JACC Cardiovasc Interv Sep"},{"key":"4061_CR35","doi-asserted-by":"publisher","unstructured":"Mahajan P, Aedma SK, Ally S, Garg A. AngioVac system guided removal of vegetations from pacemaker lead-related infective endocarditis. BMJ Case Rep Jan. 2023;20(1). https:\/\/doi.org\/10.1136\/bcr-2022-251097.","DOI":"10.1136\/bcr-2022-251097"},{"key":"4061_CR36","doi-asserted-by":"publisher","unstructured":"Tarzia V, Ponzoni M, Evangelista G, et al. Vacuum-Implemented Removal of Lead Vegetations in Cardiac Device-Related Infective Endocarditis. J Clin Med Aug. 2022;07(15). https:\/\/doi.org\/10.3390\/jcm11154600.","DOI":"10.3390\/jcm11154600"},{"issue":"3","key":"4061_CR37","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.4022\/jafib.1455","volume":"9","author":"RHM Schaerf","year":"2016","unstructured":"Schaerf RHM, Najibi S, Conrad J. Percutaneous Vacuum-Assisted Thrombectomy Device Used for Removal of Large Vegetations on Infected Pacemaker and Defibrillator Leads as an Adjunct to Lead Extraction. J Atr Fibrillation. 2016;9(3):1455. https:\/\/doi.org\/10.4022\/jafib.1455.","journal-title":"J Atr Fibrillation"},{"issue":"6","key":"4061_CR38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0022-5223(19)33944-3","volume":"102","author":"A Arbulu","year":"1991","unstructured":"Arbulu A, Holmes RJ, Asfaw I. Tricuspid valvulectomy without replacement. Twenty years\u2019 experience. J Thorac Cardiovasc Surg Dec. 1991;102(6):917\u201322.","journal-title":"J Thorac Cardiovasc Surg Dec"},{"issue":"2","key":"4061_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jtcvs.2021.10.048","volume":"166","author":"ML Paras","year":"2023","unstructured":"Paras ML, Wolfe SB, Bearnot B, et al. Multidisciplinary team approach to confront the challenge of drug use\u2013associated infective endocarditis. J Thorac Cardiovasc Surg. 2023;166(2):457\u201364. e1.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4061_CR40","doi-asserted-by":"crossref","unstructured":"Weimer MB, Falker CG, Seval N et al. The need for multidisciplinary hospital teams for injection drug use-related infective endocarditis. J Addict Med. 2022.","DOI":"10.1097\/ADM.0000000000000916"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04061-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:03:31Z","timestamp":1782176611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04061-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04061-5","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient informed consent waived by IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patient informed consent waived by IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}